Lawrence Recht
Academic Appointments
- Professor - Med Center Line, Neurology & Neurological Sciences
- Member, Bio-X
- Member, Stanford Cancer Institute
- Professor - Med Center Line (By courtesy), Neurosurgery
Key Documents
Contact Information
-
Clinical Offices
Stanford Cancer Center - Neuro Oncology 875 Blake Wilbur Dr Rm CC2221 Stanford, CA 94305 Tel Work (650) 725-8630 Fax (650) 498-4686Neuro-Oncology Clinic 875 Blake Wilbur Dr Clinic D Stanford, CA 94305 Tel Work (650) 725-8630
- Academic Offices
Personal Information Email Tel (650) 725-8630Alternate Contact Gina Anderson Administrative Assistant Email Tel Work 725-8630Not for medical emergencies or patient use
Professional Overview
Clinical Focus
- Cancer> Neuro Oncology
- Neurology
Professional Education
| Residency: | University of Minnesota School of Medicine MN (1979) |
| Fellowship: | Memorial Sloan-Kettering Cancer Center, NY USA (1984) |
| Board Certification: | Neurology, American Board of Psychiatry and Neurology (1983) |
| Residency: | New York Presbyterian Hospital NY (1982) |
| Internship: | University of Minnesota School of Medicine MN (1978) |
| Medical Education: | Columbia Presbyterian Medical Center NY (1977) |
Scientific Focus
Current Research Interests
Our laboratory focuses on two interrelated projects: (1) assessment of glioma development within the framework of the multistage model of carcinogenesis through utilization of the rodent model of ENU neurocarcinogenesis; and (2) assessment of stem cell specification and pluripotency using an embryonic stem cell model system in which neural differentiation is induced.
Clinical Trials
- Recruiting Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
- Not Recruiting XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
- Not Recruiting An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
- Not Recruiting A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
- Not Recruiting A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
Publications
- Advances in the management of glioblastoma: the role of temozolomide and MGMT testing. Clin Pharmacol. 2013: 1-9
- Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. Neuro Oncol. 2013; (4): 433-41
- Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab. 2013; (5): 732-43
- Steroid-sparing effect of corticorelin acetate in peritumoral cerebral edema is associated with improvement in steroid-induced myopathy. J Clin Oncol. 2013; (9): 1182-7
- Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage. J Biol Chem. 2013; (5): 3097-111
- Alterations in cerebrospinal fluid proteins in a presymptomatic primary glioma model. PLoS One. 2012; (11): e49724
Help
Trial Administration